What Happened?
South San Francisco, CA-based Nkarta-Therapeutics Appointed Paul Hastings as President and Chief Executive Officer
About the Company
Nkarta is a clinical-stage biotechnology company advancing the development of allogeneic natural killer (NK) cell therapies for cancer. By combining its cell expansion and cryopreservation platform with proprietary cell engineering technologies, Nkarta is building a pipeline of cell therapy candidates generated by efficient manufacturing processes, and engineered to enhance tumor targeting and improve persistence for sustained activity in the body.
About the Person
Paul Hastings is President and Chief Executive Officer at Nkarta Therapeutics. Previously, Paul held various senior HR leadership roles in the industry.
Info Source
News
Short Profile